Compare Abbott India with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs NATCO PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA NATCO PHARMA ABBOTT INDIA/
NATCO PHARMA
 
P/E (TTM) x 56.5 24.5 230.7% View Chart
P/BV x 16.7 3.6 457.3% View Chart
Dividend Yield % 0.4 0.9 44.5%  

Financials

 ABBOTT INDIA   NATCO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
NATCO PHARMA
Mar-19
ABBOTT INDIA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834849 1,040.5%   
Low Rs5,458557 979.8%   
Sales per share (Unadj.) Rs1,731.1573.8 301.7%  
Earnings per share (Unadj.) Rs211.9176.0 120.4%  
Cash flow per share (Unadj.) Rs219.9198.2 110.9%  
Dividends per share (Unadj.) Rs65.006.25 1,040.0%  
Dividend yield (eoy) %0.90.9 102.3%  
Book value per share (Unadj.) Rs945.2842.7 112.2%  
Shares outstanding (eoy) m21.2536.50 58.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.11.2 336.9%   
Avg P/E ratio x33.74.0 844.2%  
P/CF ratio (eoy) x32.53.5 916.2%  
Price / Book Value ratio x7.60.8 906.3%  
Dividend payout %30.73.6 863.7%   
Avg Mkt Cap Rs m151,84825,660 591.8%   
No. of employees `0003.55.0 70.3%   
Total wages/salary Rs m4,3563,559 122.4%   
Avg. sales/employee Rs Th10,555.54,225.3 249.8%   
Avg. wages/employee Rs Th1,249.9718.0 174.1%   
Avg. net profit/employee Rs Th1,292.21,295.9 99.7%   
INCOME DATA
Net Sales Rs m36,78620,945 175.6%  
Other income Rs m1,1331,302 87.0%   
Total revenues Rs m37,91922,247 170.4%   
Gross profit Rs m6,0477,948 76.1%  
Depreciation Rs m169810 20.9%   
Interest Rs m23193 11.7%   
Profit before tax Rs m6,9898,247 84.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4851,823 136.3%   
Profit after tax Rs m4,5036,424 70.1%  
Gross profit margin %16.437.9 43.3%  
Effective tax rate %35.622.1 160.9%   
Net profit margin %12.230.7 39.9%  
BALANCE SHEET DATA
Current assets Rs m27,61023,472 117.6%   
Current liabilities Rs m8,5697,287 117.6%   
Net working cap to sales %51.877.3 67.0%  
Current ratio x3.23.2 100.0%  
Inventory Days Days6092 65.3%  
Debtors Days Days2788 31.1%  
Net fixed assets Rs m1,05718,648 5.7%   
Share capital Rs m213365 58.2%   
"Free" reserves Rs m19,87334,525 57.6%   
Net worth Rs m20,08630,760 65.3%   
Long term debt Rs m00-   
Total assets Rs m29,40943,031 68.3%  
Interest coverage x311.643.7 712.5%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.5 257.0%   
Return on assets %15.415.4 100.1%  
Return on equity %22.420.9 107.4%  
Return on capital %34.927.4 127.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36911,536 3.2%   
Fx outflow Rs m4,9182,939 167.4%   
Net fx Rs m-4,5498,597 -52.9%   
CASH FLOW
From Operations Rs m4,9916,688 74.6%  
From Investments Rs m-2,570-6,122 42.0%  
From Financial Activity Rs m-1,428-509 280.6%  
Net Cashflow Rs m99366 1,505.0%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 1.5 5,102.0%  
Indian inst/Mut Fund % 7.9 7.8 100.8%  
FIIs % 0.1 16.6 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 26.0 65.8%  
Shareholders   18,270 25,395 71.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TORRENT PHARMA  ALEMBIC PHARMA  ELDER PHARMA  PFIZER  DR. DATSONS LABS  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)

Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 7, 2020 03:35 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS